The epidemiology of interstitial lung disease and its association with lung cancer.
about
Interstitial Lung Disease in Childhood: Clinical and Genetic AspectsAgeing and the epidemiology of multimorbidityEvaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humansLung cancer and interstitial lung diseases: a systematic reviewHigh-resolution CT of complications of idiopathic fibrotic lung diseaseProteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patientsIs there a uniform approach to the management of diffuse parenchymal lung disease (DPLD) in the UK? A national benchmarking exercise.The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study.Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study.Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung diseaseInterstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data.Surfactant protein A2 mutations associated with pulmonary fibrosis lead to protein instability and endoplasmic reticulum stress.Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis.Interstitial lung diseases in children.Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repairPulmonary toxicity related to systemic treatment of nonsmall cell lung cancer.Experimental induction of pulmonary fibrosis in horses with the gammaherpesvirus equine herpesvirus 5.Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care.Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosisClinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance studyMacrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis.Incidence of interstitial pneumonitis among breast cancer patients: a 10-year Danish population-based cohort studyClinical use of biomarkers of survival in pulmonary fibrosis.The Efficacy and Safety of Chemotherapy in Patients With Nonsmall Cell Lung Cancer and Interstitial Lung Disease: A PRISMA-Compliant Bayesian Meta-Analysis and Systematic Review.Risk of the preoperative underestimation of tumour size of lung cancer in patients with idiopathic interstitial pneumonias.Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan.Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study.Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF).Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease.The use of adaptive intensity-modulated radiotherapy in the treatment of small-cell carcinoma lung refractory to chemotherapy in a patient with preexisting interstitial lung disease.The Safety and Efficacy of Treatment with Nab-Paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias.Volume doubling time of lung cancer detected in idiopathic interstitial pneumonia: comparison with that in chronic obstructive pulmonary disease.Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer.The Ratio KL-6 to SLX in Serum for Prediction of the Occurrence of Drug-Induced Interstitial Lung Disease in Lung Cancer Patients with Idiopathic Interstitial Pneumonias Receiving Chemotherapy.Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease.[Interstitial lung disease associated with lung cancer treatment].Lung cancer and interstitial lung disease: a literature reviewSurvival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study
P2860
Q26778109-6139C98B-35CD-4307-9A7C-3714C3D7FD63Q27012096-0EAB4F39-E2B7-4203-AE83-224D46EFD953Q27908506-2EA79208-2A50-4905-A141-49E57422D26AQ28387238-C399E606-9189-4D2A-BCB7-1AB69D6AD72FQ30462254-D0C76B8F-82E3-49E6-9A48-ADA2E3E03C2AQ31026775-15573E0E-4496-45FC-AC5D-F20DC2131FF0Q33278156-D4760C70-92B4-4F53-A3C5-7407FFE20AFBQ33382518-2106BD84-AB28-416E-A00C-969EB1CD5A81Q33600748-BC75D06B-FD84-49AD-B673-BFF178D1D598Q33938475-F0B08247-367F-40A4-AAB5-4D4472D6ACB3Q33970386-2858E84B-44D6-4CD3-92B8-B0BD4CF5F15EQ33991198-D1678358-E9EE-4203-BBC0-A7D6238E9DE1Q34069594-E108B583-2358-4E8D-A634-120B9FF18255Q34128163-7F503C00-2FC7-468F-8B11-1B5FEAE48074Q34268934-C6B6F6C1-B216-41D0-9B97-F915E0A9A230Q34626688-95A8D914-D231-4049-8753-596A489266E8Q35023396-FC1055E3-4A16-49F0-AC41-B978F22250A4Q35999625-E3BF63BE-F4B4-4BD4-B0CF-9167EB41C1F0Q36049753-2C0AA51E-EAE9-47E0-BCE7-67A57CAFB899Q36337416-71786807-7561-43E6-A69F-387BDDA78A44Q36693106-D3242805-017A-4A06-AC78-EF6FC5B45DCDQ36696444-D17C9F44-CDB6-417A-AB30-900A90D2EDB4Q37768235-C35A32AC-E527-45C4-8BC2-BF61B7B4A67EQ38584229-D90CB7C5-7C4F-4BEC-A197-F7D3B2AB9D4EQ38778718-1A24D4B5-A145-4B97-AF81-D0DD5C899402Q39769492-A4E1AE8B-5E8B-4A27-A8BF-0C9F052BE589Q39808352-F4023CC1-9F50-4120-8F1A-EC717C71D433Q43035229-6F624CFC-6985-43E9-AEC9-1564D2D31DD2Q46704761-2867649F-018B-4B5B-83EF-319ED7229AFBQ47216049-0C59C3C9-74CC-4C27-A83C-DEA01542D6ACQ47608285-FF8D92D6-AD4B-4F16-8AC8-7A9E2D9D8911Q49311889-38388210-EFD7-40C2-A265-257AF957E064Q50046190-2F2D5A36-8E8C-4F67-933B-A63B5DB27156Q50077821-19CD71B3-8709-416B-9966-C7EAB4BEC70CQ50609335-396F6B66-3995-443A-90C7-7A6FB09C3858Q51601055-6761F836-CE00-4E6C-B9FC-5F58F4C982C2Q53059515-41C38C9F-29DE-45C5-A4C4-4C730BBD5CDFQ55465401-5A63A2FD-9EB2-4146-90C1-17DB5A9D7CABQ56243543-BC092BEE-0E89-4552-B8C0-E77A9B3D80F5Q58791524-564A96D5-C749-4E56-961D-BBA29D1C2CF2
P2860
The epidemiology of interstitial lung disease and its association with lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The epidemiology of interstitial lung disease and its association with lung cancer.
@ast
The epidemiology of interstitial lung disease and its association with lung cancer.
@en
type
label
The epidemiology of interstitial lung disease and its association with lung cancer.
@ast
The epidemiology of interstitial lung disease and its association with lung cancer.
@en
prefLabel
The epidemiology of interstitial lung disease and its association with lung cancer.
@ast
The epidemiology of interstitial lung disease and its association with lung cancer.
@en
P2093
P2860
P921
P356
P1476
The epidemiology of interstitial lung disease and its association with lung cancer.
@en
P2093
P2860
P2888
P356
10.1038/SJ.BJC.6602061
P407
P478
91 Suppl 2
P577
2004-08-01T00:00:00Z